UDR, Inc. · UDR · FY2025 Q3 · Calendar Q4 2025
UDR Raises FFOA Guidance Despite Slower Rent Growth
UDR's current analysis supports a cautiously constructive operating thesis: resilient occupancy, resident retention, other-income growth and disciplined capital allocation can support cash-flow growth, but the case depends on managing slower rent growth, Sunbelt supply and concessions.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about UDR FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis adds a second 2025 FFOA guidance increase, a planned 406-unit Northern Virginia acquisition, and a $350 million term-loan extension to 2029 with a lower credit spread and a fixed-rate swap at 4%. At the same time, lease-rate growth is slowing, especially in Sunbelt markets.
Guidance delta
Management raised full-year 2025 FFOA guidance to $2.53-$2.55 per share, while the analysis notes slower lease-rate growth, particularly in Sunbelt markets.
Key takeaways
- Same-store revenue and NOI growth modestly exceeded expectations, with occupancy near 96%.
- Resident retention and other-income services remain important operating supports.
- Management is pairing data-driven capital allocation with opportunistic acquisitions and continued balance-sheet management.
- The main counterweight is decelerating rent growth and possible pressure from concessions and new Sunbelt supply.
Management priorities
- Use data analytics to guide capital allocation and resident-experience initiatives.
- Pursue opportunistic acquisitions, including the Northern Virginia community.
- Maintain share buybacks while extending maturities and managing leverage.
- Focus on cash-flow growth and provide 2026 guidance in February.
Follow UDR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 21, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Sep 17, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 8, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 12, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Aug 4, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Jul 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 14, 2026 |
| Truist Securities | Hold | Buy | Downgrade | Jul 8, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 6, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 17, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 17, 2026 |
| UBS | Buy | Buy | Maintain | Jan 8, 2026 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Feb 13, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Aug 5, 2024 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 15, 2024 |
| Baird | Outperform | Outperform | Maintain | Mar 12, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Dec 13, 2023 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 31, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 15, 2023 |
| Jefferies | Buy | Buy | Maintain | Oct 19, 2022 |
| Capital One | Overweight | Equal Weight | Upgrade | Nov 16, 2021 |
| BTIG | Buy | Neutral | Upgrade | Sep 13, 2021 |
| Stifel | Buy | Buy | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 2, 2020 |
| Capital One Financial | Overweight | Equal Weight | Upgrade | Sep 16, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 25, 2018 |
| Bank of America | Buy | Buy | Maintain | Jun 8, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Jun 30, 2017 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jan 19, 2016 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jan 12, 2016 |
| Miller Tabak | Sell | Hold | Downgrade | Nov 9, 2015 |
| Credit Suisse | Neutral | Underperform | Upgrade | Oct 27, 2015 |
| ISI Group | Buy | Neutral | Upgrade | Nov 18, 2013 |
| Compass Point | Neutral | Neutral | Maintain | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $33.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $41 | $33.78 | +23.2% | Sep 21, 2026 |
| UBS | Ami Probandt | $41 | $35.37 | +23.2% | Sep 15, 2026 |
| Mizuho Securities | Analyst unavailable | $39 | $36.38 | +17.2% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $43 | $36.95 | +29.2% | Sep 1, 2026 |
| Deutsche Bank | Peter Abramowitz | $44 | $37.92 | +32.3% | Aug 14, 2026 |
| Morgan Stanley | Analyst unavailable | $42 | $37.3 | +26.2% | Aug 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $41 | $38.7 | +23.2% | Aug 3, 2026 |
| Goldman Sachs | Julien Blouin | $38 | $38.3 | +14.2% | Jul 30, 2026 |
| Wells Fargo | Analyst unavailable | $44 | $39.57 | +32.3% | Jul 22, 2026 |
| Deutsche Bank | Peter Abramowitz | $45 | $39.74 | +35.3% | Jul 20, 2026 |
| Barclays | Richard Hightower | $46 | $40.18 | +38.3% | Jul 14, 2026 |
| Scotiabank | Nicholas Yulico | $41 | $39.79 | +23.2% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $41 | $39.37 | +23.2% | Jun 10, 2026 |
| Scotiabank | Analyst unavailable | $38 | $37.52 | +14.2% | May 14, 2026 |
| Barclays | Analyst unavailable | $41 | $36.91 | +23.2% | May 11, 2026 |
| Cantor Fitzgerald | Richard Anderson | $39 | $36.39 | +17.2% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $35 | $34.25 | +5.2% | Apr 17, 2026 |
| Piper Sandler | Analyst unavailable | $41 | $38.09 | +23.2% | Feb 17, 2026 |
| Goldman Sachs | Analyst unavailable | $39 | $38.17 | +17.2% | Feb 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $42 | $39.38 | +26.2% | Feb 11, 2026 |
| RBC Capital | Brad Heffern | $39 | $39.38 | +17.2% | Feb 10, 2026 |
| Goldman Sachs | Julien Blouin | $37.5 | $37.64 | +12.7% | Jan 20, 2026 |
| UBS | Michael Goldsmith | $42 | $36.82 | +26.2% | Jan 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $37 | $36.55 | +11.2% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $41 | $36.42 | +23.2% | Dec 1, 2025 |
| Barclays | Analyst unavailable | $44 | $35.63 | +32.3% | Nov 25, 2025 |
| Mizuho Securities | Analyst unavailable | $38 | $35.59 | +14.2% | Nov 24, 2025 |
| Goldman Sachs | Analyst unavailable | $33 | $33.79 | -0.8% | Nov 4, 2025 |
| Piper Sandler | Analyst unavailable | $39 | $33.69 | +17.2% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $44 | $35.71 | +32.3% | Oct 13, 2025 |
| Wells Fargo | Analyst unavailable | $41 | $35.71 | +23.2% | Oct 13, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $40 | $37.26 | +20.2% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $45 | $36.94 | +35.3% | Sep 30, 2025 |
| Evercore ISI | Steve Sakwa | $45 | $38.37 | +35.3% | Sep 15, 2025 |
| BMO Capital | Analyst unavailable | $44 | $38.39 | +32.3% | Sep 4, 2025 |
| Truist Financial | Michael Lewis | $43 | $38.95 | +29.2% | Aug 26, 2025 |
| Morgan Stanley | Adam Kramer | $44.5 | $37.83 | +33.8% | Aug 13, 2025 |
| Evercore ISI | Steve Sakwa | $46 | $40.8 | +38.3% | Jul 7, 2025 |
| RBC Capital | Brad Heffern | $46 | $45.34 | +38.3% | Oct 1, 2024 |
| Evercore ISI | Steve Sakwa | $43 | $44.05 | +29.2% | Sep 9, 2024 |
| Goldman Sachs | Julien Blouin | $42 | $44.92 | +26.2% | Sep 4, 2024 |
| Evercore ISI | Steve Sakwa | $42 | $43.64 | +26.2% | Aug 28, 2024 |
| Piper Sandler | Alexander Goldfarb | $46 | $43.3 | +38.3% | Aug 26, 2024 |
| BMO Capital | Juan Sanabria | $45 | $40.56 | +35.3% | Jul 15, 2024 |
| Robert W. Baird | Amanda Sweitzer | $42 | $39.02 | +26.2% | May 24, 2024 |
| Scotiabank | Nicholas Yulico | $42 | $39.28 | +26.2% | May 14, 2024 |
| Scotiabank | Sector Perform | $39 | $38.08 | +17.2% | May 1, 2024 |
| UBS | Michael Goldsmith | $44 | $37.89 | +32.3% | Apr 25, 2024 |
| Piper Sandler | Alexander Goldfarb | $40 | $37.87 | +20.2% | Apr 10, 2024 |
| Truist Financial | Michael Lewis | $42 | $37.63 | +26.2% | Apr 9, 2024 |
| Wells Fargo | James Feldman | $39 | $37.28 | +17.2% | Mar 4, 2024 |
| UBS | Michael Goldsmith | $43 | $38.04 | +29.2% | Sep 19, 2023 |
| Scotiabank | Nicholas Yulico | $45 | $40.19 | +35.3% | Aug 30, 2023 |
| Scotiabank | Nicholas Yulico | $58 | $46.48 | +74.3% | May 19, 2022 |
| Piper Sandler | Alexander Goldfarb | $57 | $51.83 | +71.3% | May 4, 2022 |
| Truist Financial | Michael R Lewis | $59 | $56.75 | +77.3% | Dec 6, 2021 |
| Wells Fargo | Tammi Fique | $61 | $54.93 | +83.3% | Nov 22, 2021 |
| Capital One Financial | Neil Malkin | $64 | $55.43 | +92.4% | Nov 16, 2021 |
| Morgan Stanley | Richard Hill | $59.5 | $54.19 | +78.8% | Nov 8, 2021 |
| Goldman Sachs | Chandni Luthra | $60 | $52.95 | +80.3% | Sep 23, 2021 |
| Piper Sandler | Alexander Goldfarb | $58 | $54.23 | +74.3% | Sep 1, 2021 |
Track every rating change on UDR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationUDR, Inc. (NYSE: UDR), a distinguished S&P 500 company, stands as a premier multifamily real estate investment trust. The company boasts a proven history of generating exceptional and reliable returns for its investors, achieving this through the astute management, acquisition, disposition, development, and redevelopment of appealing real estate properties situated in key U.S. markets. As of September 30, 2020, UDR's extensive portfolio included ownership or partial ownership in 51,649 apartment homes, with an additional 1,031 units currently under development. With over 48 years in operation, UDR has consistently delivered long-term value to its shareholders, provided superior service to its residents, and fostered a high-quality experience for its associates.
Historical context
All UDR earningsLatest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the UDR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-03T19:30:44.917188+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T19:30:44.914467+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.